News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alcon Receives Approvable Letter For EXTRAVAN (TM)


10/19/2005 5:11:29 PM

Alcon, Inc. (NYSE:ACL) today announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for EXTRAVAN(TM) ophthalmic solution for the treatment of glaucoma. EXTRAVAN(TM) solution is a fixed combination of travoprost 0.004 percent and timolol 0.5 percent.

Read at AP
Read at BioSpace.com

comments powered by Disqus
AP
BioSpace.com
   
Glaucoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES